Results
2
Companies with a Future performance score of at least 3, ordered by Future performance score.
2 companies
PharmaEssentia
Market Cap: NT$166.4b
A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.
6446
NT$500.00
7D
2.5%
1Y
19.3%
Caliway Biopharmaceuticals
Market Cap: NT$135.6b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$877.00
7D
-0.3%
1Y
108.6%